Literature DB >> 14675076

Treatment of primary IgA nephropathy.

Efstathios Alexopoulos1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 14675076     DOI： 10.1111/j.1523-1755.2004.00437.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN： 0085-2538            Impact factor:   10.612


× No keyword cloud information.
  11 in total

1.  Biopsy timing and Oxford classification variables in childhood/adolescent IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Masashi Sato; Hironobu Mukaiyama; Hiroko Togawa; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2014-06-07       Impact factor: 3.714

2.  Validity of the Oxford classification of IgA nephropathy in children.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Hiroko Togawa; Yuya Hashimura; Hiroshi Kaito; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2011-12-02       Impact factor: 3.714

3.  Crescentic IgA nephropathy in children.

Authors:  Yuko Shima; Koichi Nakanishi; Taketsugu Hama; Hironobu Mukaiyama; Masashi Sato; Yu Tanaka; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2020-01-28       Impact factor: 3.714

4.  Steroids and azathioprine in the treatment of IgA nephropathy.

Authors:  Maria Stangou; Domniki Ekonomidou; Panagiotis Giamalis; Helen Liakou; Apostolis Tsiantoulas; Afroditi Pantzaki; Aikaterini Papagianni; George Efstratiadis; Efstathios Alexopoulos; Dimitrios Memmos
Journal:  Clin Exp Nephrol       Date:  2011-02-08       Impact factor: 2.801

5.  IgA nephropathy with presentation of nephrotic syndrome at onset in children.

Authors:  Yuko Shima; Koichi Nakanishi; Masashi Sato; Taketsugu Hama; Hironobu Mukaiyama; Hiroko Togawa; Ryojiro Tanaka; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Hiroyuki Suzuki; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2016-10-06       Impact factor: 3.714

6.  Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).

Authors:  Yuko Shima; Koichi Nakanishi; Mayumi Sako; Mari Saito-Oba; Yuko Hamasaki; Hiroshi Hataya; Masataka Honda; Koichi Kamei; Kenji Ishikura; Shuichi Ito; Hiroshi Kaito; Ryojiro Tanaka; Kandai Nozu; Hidefumi Nakamura; Yasuo Ohashi; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2018-10-03       Impact factor: 3.714

7.  Long-term outcome of childhood IgA nephropathy with minimal proteinuria.

Authors:  Asumi Higa; Yuko Shima; Taketsugu Hama; Masashi Sato; Hironobu Mukaiyama; Hiroko Togawa; Ryojiro Tanaka; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Koichi Nakanishi; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2015-08-04       Impact factor: 3.714

8.  Combination therapy with mizoribine for severe childhood IgA nephropathy: a pilot study.

Authors:  Norishige Yoshikawa; Koichi Nakanishi; Kenji Ishikura; Hiroshi Hataya; Kazumoto Iijima; Masataka Honda
Journal:  Pediatr Nephrol       Date:  2008-01-26       Impact factor: 3.714

9.  Improved renal survival in Japanese children with IgA nephropathy.

Authors:  Nahoko Yata; Koichi Nakanishi; Yuko Shima; Hiroko Togawa; Mina Obana; Mayumi Sako; Kandai Nozu; Ryojiro Tanaka; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

10.  Clinicopathological significance of glomerular capillary IgA deposition in childhood IgA nephropathy.

Authors:  Yuko Shima; Koichi Nakanishi; Hironobu Mukaiyama; Yu Tanaka; Takuzo Wada; Ryojiro Tanaka; Hiroshi Kaito; Kandai Nozu; Mayumi Sako; Kazumoto Iijima; Norishige Yoshikawa
Journal:  Pediatr Nephrol       Date:  2020-10-04       Impact factor: 3.714
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.